Vycor Medical, Inc.
VYCO
$0.20
$0.0314.29%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 91.47% | 56.25% | -7.37% | -53.66% | -107.84% |
| Total Depreciation and Amortization | 2.90% | 3.41% | 5.57% | 5.10% | 1.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 395.07% | 387.80% | 169.48% | 178.90% | 31.48% |
| Change in Net Operating Assets | -194.43% | -126.58% | 9.14% | 167.03% | 1,756.30% |
| Cash from Operations | -187.58% | -110.32% | 367.16% | 104.42% | 1,193.68% |
| Capital Expenditure | 69.91% | 6.38% | 44.68% | 44.68% | -253.13% |
| Sale of Property, Plant, and Equipment | -20.00% | 450.00% | -40.00% | 900.00% | 900.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 74.51% | 17.39% | 46.07% | 55.91% | -229.03% |
| Total Debt Issued | -0.51% | -0.65% | -3.33% | -3.33% | -64.10% |
| Total Debt Repaid | 8.54% | 0.00% | -8.49% | -9.06% | 44.53% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.92% | -11.43% | -447.06% | -3,900.00% | -110.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.54% | -129.74% | 538.46% | 137.93% | 141.80% |